293P Exploring the interplay between tumor burden and liquid biopsy longitudinal evaluation in hormone receptor-positive, HER2-negative metastatic breast cancer (MBC). - Mazzeo, R.; Bortot, L.; Michelotti, A.; Buriolla, S.; Palmero, L.; Franzoni, A.; Bertoli, E.; Targato, G.; Allegri, L.; Da Ros, L.; Alberti, M.; Di Nardo, P.; et al. (Annals of Oncology, 2021)